Skip to content Skip to navigation

Continuing Education Quiz

July 1, 2007
by root
| Reprints

Earn continuing education credits by taking this quiz on the article that begins on page 50 of this issue. A grade of 70% or above will earn you a certificate of completion for two nationally certified continuing education hours. This is an open-book quiz. After reading the article, complete the quiz by circling one of the three multiple-choice answers for each question. Please give only one response per question. Incomplete answers will be marked as incorrect. Send a photocopy of the page along with your payment of $35. Please complete fully the information section below; print clearly.

Integrating pharmacotherapy with treatment planning for alcohol dependence

1. A patient who participates directly in individualized treatment planning efforts is likely to improve on this dimension.

a. Engagement in treatment

b. Self-awareness

c. Number of consecutive days abstinent

2. One of the important treatment planning attributes spelled out in the acronym “SMART” involves the need for plans and goals to be:

a. Reportable.

b. Realistic.

c. Reliable.

3. A well-conceived treatment plan includes a description of patient problems, treatment goals, planned interventions, time frames, and:

a. Patients' financial resources.

b. Staff involved in treatment.

c. Planned assessment.

4. The measurable actions that patients will take to meet treatment goals are referred to as:

a. Interventions.

b. Plans.

c. Objectives.

5. The evidence basis indicating additional benefits from using more than one medication for alcohol dependence at a time is generally characterized as:

a. Not overwhelming.

b. Strong.

c. Inconclusive.

6. This medication for the treatment of alcohol dependence is often prescribed for patients who require immediate abstinence.

a. Naltrexone

b. Disulfiram

c. Acamprosate

7. This medication for the treatment of alcohol dependence is considered a logical choice when a patient is still drinking and may be experiencing intense cravings.

a. Naltrexone

b. Disulfiram

c. Acamprosate

8. This medication may be particularly suited to patients experiencing difficulty with treatment adherence because they are forgetful.

a. Extended-release naltrexone

b. Disulfiram

c. Acamprosate

9. The manufacturers of extended-release naltrexone and this medication have established referral networks of alcohol treatment centers and providers.

a. Traditional naltrexone

b. Disulfiram

c. Acamprosate

10. Although counselors do not prescribe, their support role for patients taking medications could involve encouraging adherence and monitoring:

a. New research.

b. Side effects.

c. Cost changes.